Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9ULW5
UPID:
RAB26_HUMAN
Alternative names:
-
Alternative UPACC:
Q9ULW5; B2RAA6; Q3L6K5; Q6NXS7
Background:
Ras-related protein Rab-26 plays a pivotal role in intracellular membrane trafficking, regulating the transport of specific receptors and enzymes to their designated locations within the cell. It orchestrates the journey of vesicles from their formation to their fusion with membranes, ensuring the precise delivery of cargo such as ADRA2A and ADRA2B to the cell membrane, and facilitating the secretion of digestive enzymes in the stomach and salivary glands.
Therapeutic significance:
Understanding the role of Ras-related protein Rab-26 could open doors to potential therapeutic strategies. Its involvement in critical cellular processes highlights its potential as a target for modulating disease mechanisms related to vesicle trafficking and secretion.